Purpose To evaluate hot melt extrusion (HME) and injection molding (IM) for the continuous manufacturing of IR tablets. Methods Polymeric fillers were mixed with plasticizers and functional adjuvants and/or a model drug were in some cases added to the formulation. HME was performed in a single-screw extruder (Extrusiograph 19/25D, Brabender, D); tablets were obtained by cutting with a bench-top saw cylindrical products (h 4 mm) extruded using a rod-shaped (ø 8 mm) die. IM was performed in a micromolding machine (BabyPlast 6/10P, Cronoplast S.L.; Rambaldi S.r.l., I); tablets were obtained with a cylindrical (ø 8 mm, h 4 mm) mold. Disk-shaped screening items (ø 30 mm, h 1 mm) were also prepared, by cutting 1 mm thick extruded sheets or by molding with a specific mold. Products were checked for weight, thickness and mass loss in the dissolution and disintegration apparatus. The dissolution rate from drug-containing tablets was also evaluated. Results Thermoplastic polymers were evaluated as tablet fillers based on their processability and on the mass loss behavior of molded disks. Soluble polymers employed for the preparation of solid dispersions by HME or for the conventional coating of tablets and traditional fillers, such as starch, were considered. Starch-derived disintegrants were also taken into account as they have shown a thermoplastic behavior and demonstrated to maintain the potential for disintegration after processing. All polymers could be processed with no need for technological aids except for a plasticizer. Hydroxypropylcellulose (HPC)- and sodium starch glycolate (EXPCLV)-based formulations were selected for investigating the influence of a poorly-soluble model drug and of functional aids able to affect the disintegration and dissolution rate. EXPCLV-based tablets showed the most promising results, thanks to the intrinsic ability of the polymeric filler to disintegrate. The addition of soluble (e.g. sodium chloride and Kollicoat® IR), disintegrant (Explotab® and AcdiSol®) or effervescent adjuvants was demonstrated a successful strategy for the improvement of the dissolution rate. Conclusion The feasibility of IR tablets by HME and IM was demonstrated. Promising results in terms of suitable polymeric fillers and formulation strategies for promoting tablet disintegration and drug dissolution were obtained.

Continuous manufacturing of immediate release (IR) tablets by Hot-Melt Extrusion (HME) and injection molding (IM) techniques / A. Melocchi, G. Loreti, F. Casati, M. Cerea, L. Zema, A. Gazzaniga. - In: THE AAPS JOURNAL. - ISSN 1550-7416. - (2014 Nov). ((Intervento presentato al convegno AAPS Annual Meeting and Exposition tenutosi a San Diego nel 2014.

Continuous manufacturing of immediate release (IR) tablets by Hot-Melt Extrusion (HME) and injection molding (IM) techniques

A. Melocchi;G. Loreti;F. Casati;M. Cerea;L. Zema;A. Gazzaniga
2014-11

Abstract

Purpose To evaluate hot melt extrusion (HME) and injection molding (IM) for the continuous manufacturing of IR tablets. Methods Polymeric fillers were mixed with plasticizers and functional adjuvants and/or a model drug were in some cases added to the formulation. HME was performed in a single-screw extruder (Extrusiograph 19/25D, Brabender, D); tablets were obtained by cutting with a bench-top saw cylindrical products (h 4 mm) extruded using a rod-shaped (ø 8 mm) die. IM was performed in a micromolding machine (BabyPlast 6/10P, Cronoplast S.L.; Rambaldi S.r.l., I); tablets were obtained with a cylindrical (ø 8 mm, h 4 mm) mold. Disk-shaped screening items (ø 30 mm, h 1 mm) were also prepared, by cutting 1 mm thick extruded sheets or by molding with a specific mold. Products were checked for weight, thickness and mass loss in the dissolution and disintegration apparatus. The dissolution rate from drug-containing tablets was also evaluated. Results Thermoplastic polymers were evaluated as tablet fillers based on their processability and on the mass loss behavior of molded disks. Soluble polymers employed for the preparation of solid dispersions by HME or for the conventional coating of tablets and traditional fillers, such as starch, were considered. Starch-derived disintegrants were also taken into account as they have shown a thermoplastic behavior and demonstrated to maintain the potential for disintegration after processing. All polymers could be processed with no need for technological aids except for a plasticizer. Hydroxypropylcellulose (HPC)- and sodium starch glycolate (EXPCLV)-based formulations were selected for investigating the influence of a poorly-soluble model drug and of functional aids able to affect the disintegration and dissolution rate. EXPCLV-based tablets showed the most promising results, thanks to the intrinsic ability of the polymeric filler to disintegrate. The addition of soluble (e.g. sodium chloride and Kollicoat® IR), disintegrant (Explotab® and AcdiSol®) or effervescent adjuvants was demonstrated a successful strategy for the improvement of the dissolution rate. Conclusion The feasibility of IR tablets by HME and IM was demonstrated. Promising results in terms of suitable polymeric fillers and formulation strategies for promoting tablet disintegration and drug dissolution were obtained.
Settore CHIM/09 - Farmaceutico Tecnologico Applicativo
THE AAPS JOURNAL
http://abstracts.aaps.org/published/ContentInfo.aspx?conID=46344
Article (author)
File in questo prodotto:
File Dimensione Formato  
plwwxlkdol6ilka7fk8q.pdf

non disponibili

Tipologia: Publisher's version/PDF
Dimensione 13.87 kB
Formato Adobe PDF
13.87 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/239153
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact